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ABSTRACT 
 Vibrio cholerae is a natural inhabitant of 
aquatic environments and converts to a pathogen 
upon infection by a filamentous phage, CTXΦ, 
that transmits the cholera toxin encoding genes. 
This toxigenic conversion of V. cholerae has 
evident implication in both genome plasticity and 
epidemic risk, but the early stages of the infection 
have not been thoroughly studied. CTXΦ transit 
across the bacterial periplasm requires binding 
between the minor coat protein named pIII and a 
bacterial inner-membrane receptor, TolA, which is 
part of the conserved Tol-Pal molecular motor. To 
gain insight into the TolA-pIII complex, we 
developed a bacterial two-hybrid approach, named 
Oxi-BTH, suited for studying the interactions 
between disulfide bond-folded proteins in the 
bacterial cytoplasm of an E. coli reporter strain. 
We found that two of the four disulfide bonds of 
pIII are required for its interaction with TolA. By 
combining Oxi-BTH assays, NMR, and genetic 
studies, we also demonstrate that two 
intermolecular salt bridges between TolA and pIII 
provide the driving forces of the complex 
interaction. Moreover, we show that TolA residue 
R325 involved in one of the two salt bridges is 
critical for proper functioning of the Tol-Pal 
system. Our results imply that to prevent host 
evasion, CTXΦ uses an infection strategy that 
targets a highly conserved protein of Gram-
negative bacteria essential for the fitness of V. 
cholerae in its natural environment.  
 
 
Phage-bacterium interaction is one of the 
driven forces for gene acquisition and bacterial 
host adaptation to their environment, and has been 
frequently associated with increased virulence of 
the bacterial host. A striking example of this 
parasitism-dependent adaptation is Vibrio 
cholerae, a bacterial natural inhabitant of 
estuarine, and the causative agent of epidemic 
disease cholera. While there are more than 200 O-
antigen serogroups described, only two have been 
reported to cause the pandemic disease cholera: 
the O1 and O139 serotypes, due to the production 
of two essential virulence factors: the Toxin Co-
regulated Pilus (TCP) and the Cholera Toxin (CT). 
Interestingly, the genes ctxAB encoding the 
enterotoxin CT are not carried by the core genome 
of the bacterium, but can be acquired after 
infection by a lysogenic bacteriophage known as 
CTXΦ (1). Once infected, the bacterium produces 
CT, and assembles new phage particles (carrying 
the ctxAB genes) that will be secreted in the 
environment, and may convert non-pathogenic V. 
cholerae cells to pathogenicity.  
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 2 
Most of the knowledge on CTXΦ infection have 
been extrapolated from the canonical model of 
Escherichia coli F-pilus-specific coliphages Ff 
(including f1Φ, fdΦ, and M13Φ). CTXΦ and FfΦ 
both belong to the genus Inovirus that are 
filamentous particles containing a circular single-
stranded DNA genome. The genome of inoviruses 
comprises about ten genes and is generally 
organized in a conserved modular structure in 
which functionally related genes are grouped 
together (For review, see (2, 3)). FfΦ and CTXΦ 
binding and uptake into the host cell relies primary 
on the minor coat protein pIII located at the distal 
tip of the phage, and present at three to five copies. 
While there is no sequence conservation between 
pIIIFf and pIIICTX, both proteins are composed of 
three distinct domains separated by two Low-
Complexity Regions (LCR) that serve as linkers. 
While the N-terminal (N1) and the central 
domains (N2) are exposed at the capsid surface, 
the C-terminal domain (N3) anchors the pIII 
protein to the phage particle through hydrophobic 
interactions (4–6). 
Filamentous phage infection of the bacterial host 
is seen as a sequential two-step process. First, 
phage recruitment occurs upon specific binding 
between the phage capsid pIII-N2 domain and a 
primary receptor exposed at the surface of the cell 
host: the conjugative F pilus for E. coli (3, 7) and 
the Toxin Co-regulated Pilus TCP for V. cholerae 
(1, 5). In E. coli, ATP-dependent retraction of the 
F pilus brings the phage in contact with the cell 
envelope, promoting its transport across the outer 
membrane (OM) by an unknown mechanism. 
Then, pIII must partially unfold to separate N1 and 
N2 domains (8). This event is crucial in the 
infection process as it unmasks pIII-N1 domain for 
subsequent binding to a second receptor: the 
TolAEc protein located in the cell envelope (8–12). 
In E. coli, it has been proposed that the pIII-
N1Ff/TolAIIIEc interaction triggers conformational 
modifications permitting the pIII-N3 domain to 
form a pore in the bacterial IM, allowing the 
subsequent phage DNA injection into the cell 
cytoplasm (13). The nature of the force driving the 
DNA out of the capsid remains unknown. 
In V. cholerae, TCP retraction seems central to the 
phage infection process, as TCP production alone 
is not sufficient to allow CTXΦ uptake (14). 
While TCP parasitism facilitates the introduction 
of CTXΦ into the host cell, subsequent phage 
binding to TolAVc appears to be the limiting step 
of the infection process (5, 6, 15). Thus, Waldor 
and collaborators have shown that a chimeric fd 
phage displaying the pIII-N1CTX domain fused to 
the pIII-N3fd domain can successfully infect V. 
cholerae cells. This demonstrates that the pIII-
N1CTX domain displayed at the tip of the capsid is 
critical and sufficient to assure host specific 
recognition in a TCP-independent manner (5).  
TolA is the central protein of the Tol-Pal cell 
envelope system, which is highly conserved in 
Gram-negative bacteria (16, 17). In addition to 
TolA, the Tol-Pal complex is composed of two IM 
proteins, TolQ and TolR, of the outer membrane 
(OM) lipoprotein Pal and of the periplasmic 
protein TolB. In several species, including E. coli 
and V. cholerae, two additional proteins complete 
the system: the periplasmic protein CpoB 
(previously YbgF) (18) and the cytoplasmic 
thioesterase YbgC (19). The Tol-Pal complex is 
suspected to function as a nanomachine, using the 
proton-motive force (pmf) of the IM to generate 
movements and to transfer energy to OM proteins. 
Multiple interactions connecting the different 
components of the Tol-Pal system have been 
identified. TolA, TolQ and TolR form a complex 
anchored in the IM. The TolA protein extends in 
the periplasm thanks to a long a2-helix (TolAII 
domain) while its globular C-terminal domain 
(TolAIII) interacts with TolB, and with Pal in the 
presence of pmf (20–22). Moreover, Pal interacts 
with TolB and with the peptidoglycan (PG) (23). 
Thus, the Tol-Pal system links the IM, the OM and 
the PG. The system is involved in maintaining OM 
integrity, conferring pleiotropic phenotypes when 
one of its genes, is mutated: increased sensitivity 
to detergents, cell filamentation in low and high 
osmolarity media, and outer membrane 
hypervesiculation (6, 24). In addition, the Tol 
system is involved in the late stage of cell division 
corresponding to the OM constriction (25) and has 
been found associated with the PBP1B-LpoB 
complex in E. coli (18). It is also required for 
proper localization of polar factor in Caulobacter 
crescentus (26) and of chemoreceptors in E. coli 
(27).  
For both coliphage and CTXΦ, structural studies 
on isolated protein domains have provided new 
insights into the complex formed with TolAIII in 
the bacterial periplasm (Fig. 1). First, the 
structures demonstrate that although the CTXΦ 
pIII-N1 and M13Φ pIII-N1 domains have only 
15% sequence identity, they are both dominantly 
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 3 
composed of β-strands, and multiple disulfide 
bonds stabilize their structures. On the bacterial 
side, TolAIIIEc and TolAIIIVc are curved structures 
mixing a-helices and β-sheets. A high-resolution 
structure of E. coli TolAIII free in solution has 
been obtained by heteronuclear NMR (Protein 
Data Bank PDB #1S62) (12), while TolAIII in 
complex with coliphage pIII-N1M13 (residues 11 to 
86) has been obtained by X-ray crystallography 
(PDB #1Tol). The structure shows that pIII-N1M13 
domain binds the concave side of TolAIIIEc, 
forming a continuous interprotein β-sheet (8). In 
2012, Ford and collaborators determined the 
crystal structure of pIII-N1CTX domain alone and 
in complex with V. cholerae TolAIII domain 
(PDB #4G7X). Surprisingly, the authors showed 
that pIII-N1CTX binds on the convex face of 
TolAIIIVc, resulting in a continuous interprotein β-
sheet (Fig. 1A). Thus, interaction between the two 
partners delineates a distinct interface compared to 
the coliphage model of infection (15).  
Filamentous phages are not the only particles that 
parasitize the Tol-Pal system to penetrate E. coli 
cells. Colicins are bacterial toxins comprising 
various types of lethal activity targeting the IM, 
the RNA, or the peptidoglycan of its bacterial 
target. Tol-dependent colicins have been shown to 
interact with one or more of the Tol proteins 
during their translocation across the periplasm, 
showing some similarities with Tol-dependent 
filamentous phage uptake. In 2012, Li and 
collaborators demonstrated that a Colicin A 
peptide (residues 53 to 107) binds on the convex 
face of TolAIIIEc, forming an intermolecular 
antiparallel β-sheet (28). 
It is puzzling to observe that despite the structural 
similarities between V. cholerae and E. coli 
TolAIII domains, the molecular binding interfaces 
with colicin A, pIIICTX and pIIIM13 differ, 
illustrating the versatile functioning of TolA as a 
periplasmic hub protein. In the present study our 
goal was to investigate the determinants allowing 
CTXΦ specific host selection and periplasm transit 
in vivo thanks to a new oxidative bacterial two-
hybrid approach combined to NMR and in vivo 
studies. 
 
Results 
Development of an oxidative bacterial two-hybrid 
approach dedicated to disulfide bond folded 
protein analysis— To gain insights into the 
mechanism of CTXΦ transit through the 
periplasm, we first analyzed the interaction that 
occurs between pIII-N1CTX and TolAIIIVc, 
compared to the pIII-N1M13 and TolAIIIEc 
interaction, using a bacterial two-hybrid (BACTH) 
approach. This system relies on the reconstitution 
of the signaling cAMP transduction cascade in an 
endogenous adenylate-cyclase-deficient strain 
(29). The TolAIII domains from V. cholerae and 
from E. coli were fused to the T18 domain in the 
pUT18 vector, while the pIII-N1 domain from 
M13 and CTX phages were fused to the T25 
domain in the pKT25 vector. Constructs were 
introduced into the E. coli BTH101 strain and co-
transformants were tested on MacConkey plates. 
As a control, we first observed that in this assay, 
the T18-TolAIIIEc construct gives a positive 
interaction signal with the colicin A N-terminal 
domain (ColAN) as previously described (10, 22, 
30), which validated our approach (Fig. 1B, left 
panel). We also observed that a T18-TolAIIIVc 
construct is unable to bind T25-ColAN, attesting 
the specificity for partner recognition between the 
two bacterial species. Then, we tested the 
TolAIIIVc and pIII-N1CTX constructs together, but 
we did not detect interaction between these 
different domains. We obtained the same negative 
result when we tried to detect TolAIIIEc/pIII-N1M13 
interaction (Fig. 1B, left panel). We hypothesized 
that this result could arise from improper folding 
of disulfide-bonded TolAIII, pIII-N1M13 or pIII-
N1CTX domains when expressed in the cell 
cytoplasm (Fig. 2, A and B).  
Thus, we envisioned that a bacterial two-
hybrid assay in an oxidative environment would 
allow the proper folding of proteins with disulfide 
bonds. Several E. coli strains, such as Origami 
(Novagen) or SHuffle (New England Biolabs) 
have been engineered to optimize the purification 
of proteins with disulfide bonds and are 
commercially available. We chose the SHuffle T7 
strain as a chassis because it is deleted for 
glutaredoxin reductase (gor) and thioredoxin 
reductase (trxB) genes, allowing disulfide bond 
formation in the cytoplasm. In addition, this strain 
expresses a cytoplasmic version of the disufide 
bond isomerase DsbC, promoting correct disulfide 
bond formation and proper oxidative folding of 
proteins containing multiple cysteines (31).  We 
transduced the cya mutation in the SHuffle strain 
to make the Oxi-BTH strain (for Oxidative 
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 4 
Bacterial Two-Hybrid). The resulting strain was 
co-transformed with the pUT18 and pKT25 
vectors expressing domains of interest. As shown 
on Figure 1B (right panel), the Oxi-BTH strain 
allowed the detection of interaction between 
TolAIIIVc and pIII-N1CTX, as well as between 
TolAIIIEc and pIII-N1M13.  Thus, we concluded 
that the Oxi-BTH strain is a powerful tool to apply 
the BACTH system to the study of disulfide-
bonded proteins. Indeed, our data suggest that in 
both E. coli and V. cholerae, disulfide bond-
dependent folding of the TolAIII domain and/or 
the phage minor capsid domain is required to 
allow binding of the two partners. Conversely, 
TolAIII Ec is able to interact with the colicin A N-
terminal domain, that does not contain cysteines, 
in both reducing and oxidizing conditions (Fig. 
1B). Finally, we did not observe cross-interaction 
between the two species (i.e. TolAIIIVc/pIII-N1M13 
or TolAIIIEc/pIII-N1CTX) despite strong structural 
conservation between E. coli and V. cholerae 
TolAIII domains. 
 
Role of disulfide bonds in TolAIIIVc/pIII-N1CTX 
interaction— Because TolAIIIVc/pIII-N1CTX 
interaction is only seen in our oxidative two-
hybrid assay, we hypothesized that one or more 
disulfide bonds might be essential for bacterial and 
phage domain recognition. To test this hypothesis, 
each disulfide bond (one in TolAIIIVc and four in 
pIII-N1CTX, Fig. 2, A and B) was sequentially 
abolished by introducing substitutions of 
individual cysteine to serine in the BACTH 
constructs. The resulting mutants were then tested 
in the Oxi-BTH assay. As shown on Figure 2C, 
TolAIIIVc (C292S) construct was still able to 
interact with pIII-N1CTX. This suggests that 
disulfide bond formation in TolAIIIVc is not 
required for CTX phage binding. We then targeted 
each of the four disulfide bonds present in pIII-
N1CTX. None of the individual mutations we 
performed was able to totally abolish binding to 
TolAIIIVc. Interestingly, mutation of the second or 
the third S-S bond (mutations C47S and C75S, 
respectively) of the phage pIII-N1 domain resulted 
in a faint interaction signal, suggesting a weaker 
binding affinity between TolAIIIVc and these two 
pIII-N1CTX mutants compared to the wild-type 
construct. In agreement with this observation, a 
pIII-N1CTX(C47S-C75S) double mutant was not 
able to interact with TolAIIIVc. These observations 
are unlikely to result from stability defects of the 
cysteine variants compared to the native pIII-N1 
protein. Indeed, inserting the same mutations on 
the his-tagged pIII-N1CTX domain expressed from 
the pIN vector resulted in equivalent expression of 
the different constructs (Fig. S1). Moreover, as the 
pIII-N1CTX/TolAIII interaction is not seen in the 
regular BACTH assay, it is more likely that pIII-
N1CTX folding via its 2nd and 3rd disulfide bonds is 
critical for TolAIIIVc binding.  
 
The CTXΦ central domain pIII-N2 does not block 
phage pIII-N1 accessibility to TolAIIIVc— It has 
been shown that Ff coliphages require an 
activation step to become able to infect the host 
cell. Indeed, in the native conformation of the 
minor capsid protein pIIIFf, the N2 domain is 
tightly associated to N1, which buries the phage 
TolAIII-binding site at the domain interface. 
Phage activation is processed upon binding of N2 
to the primary receptor, the F pilus, which initiates 
partial unfolding, prolyl cis-to-trans isomerization 
in the hinge between N1 and N2 and domain 
disassembly, thereby exposing its binding site for 
the ultimate receptor TolA (32). It has been 
proposed that the isomerization sets a molecular 
timer to maintain the binding-active state long 
enough for the phage to interact with TolA. 
Conversely, Craig and collaborators have 
suggested that the TolA binding site on pIII-N1CTX 
is permanently accessible and does not require 
initial pilus-induced conformational change (15). 
We wondered if a fusion to the two-hybrid T25 
domain would allow us to test the influence of 
pIII-N2 CTX on the accessibility of pIII-N1CTX in an 
Oxi-BTH interaction assay. Indeed, our data show 
that the T25-pIII-N1N2 CTX construct is able to 
bind T18-TolAIIIVc, while the T25-pIII-N2CTX 
domain alone is not (Fig. 2C). This result 
demonstrates that pIII-N1CTX exposes a TolAIIIVc 
binding motif that is not masked by the pIII-N2 
domain. 
 
Specific recognition between the TolAIIIVc and 
pIII-N1CTX domains relies on two salt bridges— 
We aimed to identify the residues showing a 
predominant role in the specificity of binding. 
Reversible protein-protein interactions involve low 
energy ionic bonds, hydrogen bonds and van der 
Waals interactions. Based on the co-crystal 
structure of TolAIIIVc and pIII-N1CTX (PDB 
#4G7X; (15)) we focused our analysis on the 
intermolecular salts bridges. Residues K324, R325 
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 5 
and K347 on TolAIIIVc respectively interact with 
E37, D39 and E92 on pIII-N1CTX (Fig. 3A). In 
order to analyze the importance of these three salt 
bridges in the complex formation, we abolished 
them sequentially by introducing single residue 
substitutions on TolAIIIVc. We confirmed that the 
different TolAIIIVc variants showed production 
level and stability equivalent to the wild-type T18-
TolAIII construct by immunodetection (Fig. 3B), 
and tested their capacity to interact with T25-pIII-
N1 in a Oxi-BTH assay (Fig. 3C). The 
TolAIII(K324E) and TolAIII(R325D) mutants 
were respectively partially, and totally impaired in 
their ability to interact with pIII-N1CTX, while the 
TolAIII(K347E) mutant retained its ability to bind 
pIII-N1CTX. Conversely, we introduced the mirror 
mutations on T25-pIII-N1CTX to generate the 
E37Q-D39N and the E92K variants. We 
demonstrated that T25-pIII-N1(E37Q-D39N) was 
unable to bind T18-TolAIIIVc, while T25-pIII-
N1(E92K) was. Together, these data suggested 
that the two intermolecular salt-bridges engaged 
between K324 and R325 on TolAIIIVc, and E37 
and D39 on pIII-N1CTX are crucial for pIII-
N1/TolAIIIVc complex stabilization. 
To confirm the role of the TolAIII charged patch 
[K324-R325] in pIII-N1CTX binding, we swapped 
the charged residues engaged into salt-bridges 
between the two partners. As predicted, the T18-
TolAIII(K324E-R325D) double mutant was not 
able to interact with the wild-type T25-pIII-N1CTX 
construct but regained interaction with the mutated 
variant presenting opposite charged residues T25-
pIII-N1(E37K-D39R) (Fig. 3C). Of note, the 
restored interaction signal appeared weaker than 
the one observed for wild-type constructs, possibly 
reflecting that additional local steric effects 
operate at the binding interface.   
To further establish that our data result from a 
specificity of interaction rather than a folding 
defect of the protein variants, we developed a 
NMR approach. We used the pIN3-ompA2 vector 
(33) to overproduce 15N-labelled wild-type pIII-
N1CTX, pIII-N1CTX(E37Q-D39N) and pIII-
N1CTX(E92K) variants fused to a His C-terminal 
tag. The 1H-15N HSQC spectra of the proteins (Fig. 
4A, 4C and 4E) shows 15N/1H correlations for the 
NH group of each amino acid of the proteins. The 
15N and 1H resonances are associated to the 
nucleus chemical environment, thus 1H-15N HSQC 
spectrum represents the finger print of a protein. In 
the case of the native and variant pIII-N1CTX, the 
1H-15N HSQC spectra are well resolved. This 
indicates that each residue has a particular 
environment in agreement with the x-ray structure 
of the protein (15). The fact that the spectra of the 
variant proteins are similar to that of the native 
protein demonstrates the conservation of the 
folding. Moreover, superimposition 1H-15N HSQC 
in the presence and the absence of TolAIIIVc 
showed chemical shift perturbations for pIII-
N1CTX (Fig. 4B) and pIII-N1CTX(E92K) variant 
(Fig. 4D), while no perturbation was seen with the 
pIII-N1CTX(E37Q-D39N) variant (Fig. 4F). These 
observations demonstrate that pIII-N1CTX and pIII-
N1CTX(E92K) could interact with the TolAIIIVc 
domain, modifying the chemical environment of 
nucleus located at the interface, while the pIII-
N1CTX(E37Q-D39N) variant could not, which 
confirmed the Oxi-BTH results. 
 
In V. cholerae, periplasmic expression of the CTX 
pIII-N1 domain leads to tol phenotypes— Oxi-
BTH assay and NMR studies allowed us to 
identify key residues on the CTXΦ minor capsid 
protein that were involved in TolAIII binding. In 
order to confirm these data in vivo, we used a 
periplasmic expression assay in V. cholerae. In E. 
coli, it has been previously shown that production 
of the N-terminal domain of colicin A (34) or of 
pIII-N1 domain of coliphage f1 (10) into the 
periplasm of WT cells perturbs the Tol-Pal system 
by sequestering the TolA protein, and 
consequently results in tol phenotypes. This 
approach is particularly suitable to study the 
translocation step of phage infection, as it does not 
require production and assembly of mutated phage 
particles, their TCP-dependent reception and their 
OM transport.  
We used the pIN3-ompA2 vector to express the 
his-tagged pIII-N1CTX wild-type sequence (or 
variants) fused to a N-terminal ompA signal 
sequence in order to allow transport of the 
produced proteins into the periplasm via the sec 
pathway. Correct production of the resulting 
proteins in V. cholerae cells was confirmed by 
immunodetection, while transport of the produced 
domains into the periplasm was attested by sodium 
azide inhibition of the sec pathway (Fig. S2). Cells 
producing the WT pIII-N1 phage domain targeted 
to the periplasm presented a 5-fold decrease in 
susceptibility to phage infection (Fig. 5A), high 
sensitivity to deoxycholate (DOC) (Fig. 5B) and to 
sodium dodecyl sulfate (SDS) (Fig. 5C), which are 
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 6 
characteristic tol phenotypes. This suggests that 
the exogenous pIII-N1CTX domain interacts with 
the endogenous TolAVc protein in V. cholerae cell 
envelope, competing with the other Tol proteins of 
the system, and preventing adequate functioning 
that insures membrane integrity and permits phage 
uptake. We also observed that exogenous 
production of pIII-N1M13 in V. cholerae periplasm 
does not result in tol phenotypes, which 
demonstrates further that the M13Φ capsid protein 
pIII does not bind V. cholerae TolA protein. In 
accordance with the Oxi-BTH results, periplasmic 
expression of the pIII-N1CTX(E37Q-D39N) 
construct resulted in phage infection rate, DOC 
sensitivity and SDS sensitivity similar to the 
control cells carrying an empty vector, while 
periplasmic expression of the pIII-N1CTX(E92K) 
variant showed the same phenotypes as those 
obtained with the WT pIII-N1CTX construct. In 
accordance with the Oxi-BTH results, these in vivo 
data confirm that the pIII-N1CTX negatively 
charged residues E37 and D39 are required for 
pIII-N1 interaction with the native TolA protein.  
 
Evidence that TolA R325 residue is essential to the 
Tol-Pal system proper functioning in V. 
cholerae— We decided to investigate if the TolA 
charged patch [K324-R325] required for phage 
binding is important for the Tol-Pal system 
function in V. cholerae. While multiple attempts to 
delete V. cholerae full length tolA gene by double 
homologous recombination were unsuccessful, we 
found that a TolA∆(41-421) mutant, deleted for its 
periplasmic domains but retaining its IM domain, 
is viable. The resulting strain presents 
characteristic tol phenotypes (6, 35), including 
resistance to CTXΦ infection, sensitivity to SDS 
and to DOC, and finally growth defect in a low 
osmolarity medium (tryptone broth, 66 mM NaCl) 
compared to LB medium (Fig. 6, A-E).  
We first performed a complementation assay of 
the TolA∆(41-421) mutant using a pBAD 
expression vector. TolA has been reported to be a 
low abundance protein (400 to 800 copies in E. 
coli cells, (36)). In our assay, basal level of TolA 
production from the pBAD-TolA vector was 
detected even in the absence of induction (Fig. 
6A), and was sufficient to almost fully 
complement (80% to 100% rescue) the V. cholerae 
tolA mutant for phage infection (Fig. 6B), for 
resistance to SDS and DOC (Fig. 6C and 6D) and 
for hypo-osmotic growth in tryptone broth (Fig. 
6E). These results also confirmed that the deletion 
had no polar effect on the other genes of the Tol-
Pal operon. 
We then tested V. cholerae strains carrying TolA 
variants where residues K324, R325 or K347 were 
mutated for opposite charged residues. While the 
K324E variant behaved similarly to the wild-type 
pBAD-TolA construct, rescue was no longer 
observed for the TolA(R325D) variant, in spite of 
adequate production of the mutant protein (Fig. 
6A-E). The TolA(K324E-R325D) double mutant 
showed a slightly stronger phenotype than the 
individual mutants for membrane integrity assays 
(Fig. 6C and 6D). Finally, the TolA(K347E) 
variant complemented the mutant strain similarly 
to the WT TolA construct. Together, these 
findings support the conclusion that the positively 
charged residue R325 plays a dominant role in 
TolA function in V. cholerae, while K324 and 
K347 do not.  
 
Conservation of the K324 and R325 residues in 
other TolA Vibrio species— The Tol-Pal system 
has a widespread distribution in Gram-negative 
bacteria. We first questioned TolA sequence 
conservation among 128 Vibrio cholerae isolate 
genomes available on NCBI database, and found 
that the full-length protein is 100% identical (Fig. 
S3). We then broaden the study to the 
vibrionaceae family, including 82 Vibrio species 
(Fig. S4) and 33 non-Vibrio species (6 Aliivibrio, 
3 Enterovibrio, 5 Grimontia, 13 Photobacterium 
and 6 Salinovibrio; Fig. S5). PSIPRED analysis 
(37) of the TolAIII amino acid sequences suggests 
that the secondary structures are conserved among 
Vibrionaceae (data not shown). Alignments of 
TolAIII sequences from multiple Vibrio species 
indicates that K324 is highly conserved (73/82 
sequences) with only few variants where it is 
replaced by another positively charged residue, 
arginine (6/82). Three exceptions were found with 
V. breoganii, V. gazogenes and V. rhizosphaerae 
that carry an uncharged glutamine residue at 
position 324. Overall, the positive charge at 
position 324 appears to be conserved in other 
Vibrionaceaes tested (31/33), suggesting its 
importance in TolA function (Fig. S4 and S5). 
Conversely, the positively charged residue R325 is 
less conserved in Vibrio species (51/82), 
frequently being replaced by the uncharged 
residue serine (25/82) or less frequently by 
alanine, threonine or valine (6/82). Notably, the 
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 7 
positively charged residue at position 325 was 
never observed in other Vibrionaceae species 
(0/33).  
As we previously demonstrated that pIII-N1CTX 
interaction with the V. cholerae TolA receptor is 
driven by two intermolecular salt-bridges 
engaging TolA K324 and R325 residues, we 
expected orthologous TolAIII sequences carrying 
the charged patch [K324-R325] to also be able to 
bind CTX pIII-N1. As shown in Figure 7A, the 
TolAIII domain from V. anguillarum, V. 
tasmaniensis and V. alginolyticus carry the [KR] 
patch, while V. harveyi has a [KS] motif and the 
Vibrionaceae Aliivibrio fisheri has a [KT] motif. 
The TolAIII coding sequences from the different 
species were cloned into the pUT18 vector and 
correct expression of the different constructs was 
assessed by immunodetection (Fig. 7B) before 
testing their interaction ability with T25-pIII-
N1CTX in the Oxi-BTH assay. As shown on Figure 
7C, T18-TolAIII from V. anguillarum, V. 
tasmaniensis and V. alginolyticus showed positive 
interaction signal with T25-pIII-N1CTX. In 
contrast, T18-TolAIIIV.harveyi and T18-TolAIIIV. 
fischeri, lacking the positively charged patch [KR], 
were not able to bind pIII-N1CTX.  We analyzed the 
TolAIII sequences that were able to bind pIII-N1 
in order to define a consensus sequence for partner 
recognition. We found that TolAIII tolerates 
multiple sequence variation in the β2-strand, likely 
because this region of the protein interacts with 
pIII-N1 β1-strand through backbone hydrogen-
bond interactions. Conversely, TolAIII a2-helix 
alignments allowed the definition of a consensus 
sequence 
[GD(S/T)R(L/V)CAA(T/A)KRA(V/I)AQ] 
surrounding the [KR] residues. We noticed that V. 
harveyi TolAIII carry the defined consensus 
sequence, apart from R325. However, point 
mutation to generate T18-TolAIIIV.harveyi S325R 
and reconstitute a positively charged patch [KR] 
was not sufficient to restore interaction with pIII-
N1CTX (Fig. 7C). 
 
Discussion 
A new in-vivo protein-protein interaction assay 
dedicated to disulfide oxidized proteins— For 
many proteins functioning in the periplasm, 
exposed at the cell surface, or secreted in the 
extracellular environment, stability and/or activity 
require the formation of disulfide bonds. For 
example, in V. cholerae, S-S bonds proteins 
include the cholera toxin (38), the pilin subunits 
that assemble in different type IV pili (TCP, 
MshA, PilA) operating into the various aspects of 
Vibrio ecology (39, 40), the TolA protein in the 
Tol-Pal complex involved in envelope integrity 
and cell division (15) and sensors such as TcpP 
(41, 42) and ToxR (43) operating signal 
transduction to regulate virulence pathways. Thus, 
identification and characterization of 
physiologically relevant interactions between these 
S-S bond proteins in vivo is a crucial task for the 
understanding of molecular processes within the 
cell.  
The original BACTH approach is an easy yet 
efficient technic that has become a common 
laboratory tool used to identify and dissect 
protein-protein interactions (29, 44). As the 
interaction between candidates of interest is tested 
in the cell cytoplasm, studies were restricted so far 
to proteins in their reduced state. Recently, the 
development of new BACTH plasmids inserting a 
transmembrane segment downstream of the T25 
and T18 fragments was shown to allow the 
detection of interactions occurring within the 
periplasmic space of the cell (45).  
In this study, we extended the range of BACTH 
application to the study of disulfide-oxidized 
proteins directly in the reporter cell cytoplasm 
thanks to a new genetic background, that we 
named Oxi-BTH. In this strain, correct disulfide 
reshuffling is catalyzed by a cytoplasmic version 
of the disulfide bond isomerase DsbC (31). The 
Oxi-BTH assay was validated by the visualization 
of interactions previously described between 
proteins with unique (TolAIIIEc, TolAIIIVc) and 
multiple disulfide bonds (pIII-N1M13, pIII-N1CTX), 
that could not be observed in the regular BACTH 
assay. As a protein with 8 cysteines, pIII-N1CTX 
has a probability of less than 1% to form the 
correct four disulfide bonds, our results also attest 
the efficiency of the cytoplasmic DsbC 
proofreading activity (Fig. 1). Finally, this tool 
was suitable to individually test the importance of 
each disulfide bond and of targeted residues in 
protein-protein interactions (Fig. 2 and 3). Many 
BACTH pUT18 and pKT25 constructs have 
already been published, and genome-wide libraries 
are available for E. coli (46) and P. aeruginosa 
(47) allowing the constitution of a large collection 
of potential partners that can be directly tested in 
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 8 
the Oxi-BTH assay without requiring new cloning 
steps. In this context, we believe that Oxi-BTH 
constitutes a robust and versatile tool to test the 
importance of oxidative folding in protein-protein 
interaction, to identify key amino acids involved, 
and to investigate the specificity of binding 
between two proteins of interest.  
Refining the model of CTXΦ uptake— Filamentous 
phage infection is a two-steps process, requiring a 
primary receptor at the surface of the cell (the TCP 
pilus in the case of CTXΦ) and a secondary 
receptor, TolA, inside the cell envelope. In this 
study, our aim was to gain insight into the second 
step of the infection process by investigating in 
vivo the phage-TolA interaction. At the contrary to 
E. coli, we did not manage to obtain the V. 
cholerae TolA clean deletion mutant by 
homologous recombination, while we were able to 
delete the periplasmic domains of the protein. It is 
worthy to note that the only other V. cholerae 
TolA- mutant published in the literature is a 
tolA::pGP704 disruption mutant (obtained by 
single crossover) that, according to the  primer 
design, also resulted in a truncated TolA protein 
somewhere in the periplasmic domain (6). This 
suggest that, in laboratory conditions, TolA is 
essential in V. cholerae, as previously reported in 
E. coli O7:K1 (48), Pseudomonas aeruginosa (49) 
and Caulobacter crescentus (26), while being 
dispensable E. coli K12 strain (35). 
We observed that pIII-N1CTX domain is sufficient 
for TolA binding, and that pIII-N2CTX doesn’t 
impede the interaction between the two partners 
(Fig. 2). This result is in agreement with previous 
observations made by Ford and collaborators (15). 
Indeed, the authors previously showed that CTXΦ 
incubation with an excess of purified TolAIIIVc 
domain before infection of V. cholerae O395 cells 
reduced the infection efficiency. However, in this 
study, binding between pIII-N1-N2CTX and 
TolAIII Vc had not been formally tested because 
pIII-N1-N2 CTX could not be purified in a soluble 
form (15). Together, our data further demonstrate 
that the CTXΦ naturally exposes a TolA-binding 
site on the N-terminal domain of pIII, which is 
reminiscent to IF1 and IKe coliphage infection 
strategy (50). It implies that CTXΦ binding to the 
primary receptor TCP might be responsible for 
phage recruitment from the environment and 
possibly active pulling to the cell surface through 
retraction (14) but is not required to unmask pIII-
N1 TolA binding site.  
The crystal structure of the complex (PDB 
#4G7X) suggested that multiple interactions 
(ionic, hydrophobic, polar contacts and van der 
Waals forces) contribute to the binding interface 
between TolAIIIVc and pIII-N1CTX. The TolAIIIVc 
β2-strand folds around pIII-N1CTX, resulting in a 
continuous intermolecular β-sheet that involves 
multiple hydrogen bonds between the backbone 
chains of TolAIII β2-strand and pIII-N1 β1-strand. 
TolAIIIVc residues K324, R325 and K347 form 
three salt bridges with pIII-N1 E37, D39 and E92 
residues, respectively (Figure 3). However, the 
contribution of each of the individual interaction 
in the TolAIII/pIIICTX complex formation cannot 
be assessed from the crystal structure. By 
combining in silico analysis and in vivo 
experimental data, we defined that the consensus 
sequence for CTX binding on TolAIIIVc is 
restricted to the a2-helix, while the β2-strand 
tolerates multiple residues variations (Fig. 7).  
Moreover, our work clearly demonstrates that the 
two salt bridges engaged between TolAIIIVc 
residues K324 and R325, and CTX phage pIII-N1 
residues E37 and D39 respectively, provide the 
driving forces of the interaction, forming ion locks 
required for the complex to form, while the 
TolAIII K347-pIII-N1 E92 bond is dispensable. It 
is worthy to note that mutating the TolAIII R325 
residue alone had a stronger negative impact on 
phage binding than mutating the TolAIII K324 
residue (Fig. 3). We used the 2P2I database 
(http://2p2idb.cnrs-mrs.fr/2p2i_inspector.html; 
(51, 52)) in order to gain insights into the protein-
protein interface parameters. Results showed a 
total of 88 non-bonded contacts (distance cutoff 4 
Å) between pIII-N1CTX and TolAIIIVc (Fig. S4). 
Among these 88 contacts, TolAIII R325 was 
engaged in 20 different contacts with pIII-N1 
surface, while TolAIII K324 was engaged in 6. 
These observations might explain the more 
predominant role of TolAIII R325 residue in pIII-
N1 binding, compared to K324. Overall, this is 
reminiscent of what was previously observed for 
M13 coliphage pIII-N1 binding on the concave 
side of TolAIIIEc, where the interaction makes an 
antiparallel continuous β-sheet stabilized by two 
salt bridges (TolAIIIEc D210, K212 interacting 
with pIII-N1M13 R29 and D28, respectively (PDB 
#1Tol; (8)). It would be interesting to test the 
importance of each of these ionic interactions for 
coliphage-TolAEc complex formation. 
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TolA is involved in the fitness of V. cholerae, in 
particular in low osmolarity conditions such as 
those found when the bacterium reach low salinity 
environments (fresh water), or in response to 
detergent components, such as the bile acid 
deoxycholate during its transit through the 
gastrointestinal track (Fig. 5 and Fig. 6, (6)). We 
found that the TolA(R325D) variant was 
functionally unable to complement V. cholerae tol 
mutant, while the TolA(K324E) mutant was (Fig. 
6). We questioned the sequence conservation of 
TolAIII in other vibrio species, but we didn’t 
observe strict correlation between conservation of 
the K324 and R325 residues and their importance 
in TolA function in the tested conditions. 
Interestingly, we noticed that in the 33 
Vibrionaceae species studied, the TolAIII R325 
residue is absent (Fig. S3), while additional 
positive charges are found at more or less one 
pitch of the α2 helix:  R321 (occurrence 33/33) 
and K329 (occurrence 24/33). Because TolA is a 
hub protein, and part of a multicomponent 
complex, the patch of positive residues on the α2 
helix might be involved in partners binding, either 
with an already known partner of the TolAIII 
domain such as TolB or Pal (16, 22, 53) or an 
unknown partner that still has to be identify.  
We demonstrated that the KR patch on TolA is 
crucial but not sufficient for CTX binding (Fig. 7). 
Indeed, study of the V. harveyi TolA(S325R) 
variant suggests that additional local steric effects 
operate at the binding interface, outside the α2 
helix. While salt bridges provide the forces to 
drive protein-protein initial attraction, subsequent 
complex stabilization is usually the result of 
cooperative interactions that encompass multiple 
pairwise bonds (54). Our results allow a better 
understanding of the TolAIII/pIII-N1 interaction 
interface, with two salt-bridges providing the 
driving forces of the interaction while the 
formation of the intermolecular anticontinuous β-
sheet provides stabilization interactions to the 
complex. By targeting important functional and/or 
conserved residues of TolA protein, CTXΦ uses a 
parasite infection strategy that may help to prevent 
V. cholerae from escaping the infection.  
Implication for the CTX infection host specificity 
— In this work, we observed that the CTX phage 
protein pIII-N1 responsible for host selection (5) 
can bind the TolAIII receptor domain from at least 
three other vibrio species: V. alginolyticus, V. 
anguillarum and V. tasmaniensis (Fig. 7). 
However, the host range reported for CTX from 
environmental sampling studies is surprisingly 
narrow, even in species carrying a conserved TolA 
sequence. Thus, while all the epidemic V. cholerae 
strains belonging to the O1 or O139 serogroups 
carry the CTX prophage, it is rarely detected (2 to 
5 %) in non-O1/non-O139 V. cholerae 
environmental isolate genomes (55–59). Apart 
from Vibrio cholerae, CTXΦ has been reported to 
infrequently infect other Vibrio species, even for 
very close species such as V. mimicus (60). It has 
been proposed that the limited distribution of the 
primary receptor TCP among vibrio species plays 
a predominant role in the fate of the entire 
infection process (55). It is interesting to note that 
TCP-independent CTXΦ infection has been 
reported to occur in defined conditions (5). Thus, 
while TolA is a conserved protein, variation in the 
sequence of the TolAIII domain might serve as a 
second level of CTXΦ host specificity checkpoint. 
Since bacteriophages, like any other viruses are 
obligate intracellular parasites, successful uptake 
across the bacterial cell envelope is an essential 
condition to complete their life cycle. However, 
current knowledge on host–phage interactions is 
based on a limited number of microbial models. 
This scientific problem outreaches the question of 
V. cholerae pathogenic conversion, as other 
filamentous phages (sharing similarities with 
CTXΦ) have been demonstrated to affect the 
virulence and fitness of a large range of bacterial 
host: MDA in invasive isolates of Neisseria 
meningitides (61),YpfΦ in the plague bacillus, 
Yersinia pestis (62), CUS-1 in the high-virulence 
clone Escherichia coli O18:K1:H7 (63). In this 
context, our work emphasizes the necessity to 
study CTXΦ infection on its own, and to overtake 
the Ff coliphage model of infection. It also sheds 
light on the mechanism underlying the initial 
filamentous phage –bacterial host binding, and 
provides basic knowledge that might serve the 
understanding of transduction-dependent 
spreading of virulence factors in bacterial 
populations.  
 
Experimental Procedures 
Bacterial strains and growth conditions— 
Relevant bacterial strains and plasmids used in this 
study are listed in Table S1. Bacteria were 
routinely cultivated in Luria-Bertani broth (LB, 
 by guest on June 23, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
 10 
407 mOsM) at 37°C (E. coli) or 30°C (V. 
cholerae). When specified, MgCl2 (2 mM) was 
added to the culture medium to promote OM 
integrity and cell growth of tol mutants. Tryptone 
broth (1% (w/v) Tryptone, 66 mM NaCl; pH 8.5) 
was used as a low osmolarity medium (123 
mOsM, (64)). When indicated, antibiotics were 
added to the medium at the following 
concentrations: streptomycin (100 µg/ml), 
ampicillin (50 or 100 µg/ml), kanamycin (50 
µg/ml), chloramphenicol (30 µg/ml for E. coli, 1 
µg/ml for V. cholerae). V. cholerae tolA D(41-421) 
in frame deletion mutant was constructed as 
previously described using the primers listed in 
Table S2 and the suicide plasmid pWM91 (65, 
66). The absence of the TolA protein in the mutant 
strain was confirmed by western blotting using 
polyclonal antibodies directed against E. coli 
TolAII-III protein (30) and cross-reacting with 
TolAIIIVc.  
Plasmid construction. Polymerase Chain 
Reactions (PCR) were performed using Q5 High 
Fidelity DNA polymerase (NewEngland Biolabs). 
Primer sets required to generate genetic constructs 
were synthesized by Sigma Aldrich (Table S2). 
Enzymes (NewEngland Biolabs) were used 
according to the manufacturer's instructions. 
Plasmids have been constructed either by standard 
restriction/ligation protocol, by Sequence and 
Ligase Independent Cloning (SLIC) (67) as 
modified by Jeong and collaborators (68), or by 
Restriction-Free (RF) cloning as previously 
described (69). Briefly for RF cloning, genes of 
interest were amplified with oligonucleotides 
introducing extensions annealing to the target 
vector. The double-stranded product of the first 
PCR has then been used as oligonucleotides for a 
second PCR using the target vector as template 
and Pfu Turbo polymerase (Stratagen, La Jolla, 
CA). For BACTH plasmid constructs, the V. 
cholerae El Tor N16961 genome was used as a 
template to PCR-amplify the pIIICTX encoding 
gene (orfU, at loci vc1460). The tolA sequence 
was amplified from V. cholerae O395 (locus 
VC0395_A1430) or from E. coli W3110 (locus 
BL257_RS03625) genomes. The pG3 vector (10) 
was used as a template to amplify pIIIM13. 
Amplified products were cloned into a pUT18c or 
a pKT25 expression vector (29) to generate 
fusions with the adenylate cyclase T18 and T25 
domains. For construction of the pBAD-TolA 
rescue plasmid, the native sequence of V. cholerae 
O395 TolA, retaining the start and the stop codons 
was amplified by PCR. The forward primer was 
designed to introduce a Shine Dalgarno consensus 
sequence GAAGGAGATATACATACCC directly 
upstream of the start codon. The amplification 
product was then introduced into the pBAD18-
Kan vector (70). For periplasmic expression, pIN-
pIII-N1CTX plasmid was constructed by PCR-
amplifying the pIII-N1CTX sequence (without start 
codon) with an upstream oligonucleotide encoding 
Strep-tag II (WSHPQFEK) and a downstream 
oligonucleotide encoding a C-terminal 6-His 
sequence. Digestion of the PCR product and the 
pIN-ompA2 vector (33) with EcoRI and BamHI 
enzymes allowed subsequent ligation of the PCR 
product into the vector. The pIN-PIII-N1M13 
plasmid (previously named pG3) has been 
previously described (10).  
Mutations on pUT18-TolA, pKT25-pIII-N1, pIN-
pIII-N1 and pBAD-TolA plasmids were 
performed by Quick-change site-directed 
mutagenesis using complementary pairs of 
oligonucleotides (listed in Table S2) and Pfu 
Turbo polymerase. All constructs were confirmed 
by DNA sequencing (Eurofins, MWG). 
Construction of the Oxi-BTH strain— In order to 
conduct bacterial two-hybrid experiments in an 
oxidative environment, the E. coli K12 SHuffle T7 
strain (New England Biolabs) was engineered 
further. This initial strain is deleted for 
glutaredoxin reductase (gor) and thioredoxin 
reductase (trxB) genes, which allows disulfide 
bonds formation in the cytoplasm. Moreover, 
cytoplasmic expression of the disufide bond 
isomerase DsbC acts on proteins with multiple 
disulfide bonds, promoting correct disulfide bond 
formation and proper folding. In this genetic 
background, the cya° mutation was transduced 
using a P1-lysate of an E. coli K12 cya° strain. 
The resulting mutant strain, names Oxi-BTH, was 
unable to ferment sugars, and consequently grew 
as white colonies when plated on MacConkey 
plates. 
Bacterial Two-Hybrid Assay in E. coli BTH101 
and Oxi-BTH strains— The adenylate cyclase-
based bacterial two-hybrid technique was used as 
previously published (29), with the following 
modifications. Pairs of proteins to be tested were 
fused to the isolated T18 and T25 catalytic 
domains of the Bordetella adenylate cyclase. After 
transformation of the two plasmids producing the 
fusion proteins into the reporter BTH101 or Oxi-
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BTH strains, plates were incubated at 37°C for 24 
hours. Three colonies for each transformation 
were inoculated into 600 µl of LB medium 
supplemented with ampicillin, kanamycin and 
IPTG (0.5 mM). After overnight growth at 30°C, 5 
µl of each culture were dropped onto MacConkey 
plates supplemented with ampicillin, kanamycin 
and IPTG (0.5 mM). Plates were incubated for 16 
to 24 hrs (BTH101) and 2 to 3 days (Oxi-BTH) at 
30°C. The experiments were done at least in 
triplicate and a representative assay is shown.  
SDS-PAGE and Immunoblotting— Protein 
samples resuspended in 2x loading buffer were 
subjected to sodium dodecyl sulphate (SDS)-
polyacrylamide gel electrophoresis (PAGE). When 
specified, 2-mercaptoethanol (5% final) was added 
to the samples. For detection by immunostaining, 
proteins were transferred onto nitrocellulose 
membranes, and immunoblots were probed with 
primary antibodies, and goat secondary antibodies 
coupled to alkaline phosphatase, and developed in 
alkaline buffer in presence of 5-bromo-4-chloro-3-
indolylphosphate (BCIP) and nitroblue tetrazolium 
(NBT). The anti-TolAIIIEc polyclonal antibodies is 
from our laboratory collection while the anti-5 His 
monoclonal antibody (QIAGEN), the anti-CyaA 
monoclonal antibody (3D1, Santa Cruz 
Biotechnology) and alkaline phosphatase-
conjugated goat anti-rabbit and anti-mouse 
antibodies (Millipore) have been purchased as 
indicated. 
V. cholerae phenotypic analysis—  
Sensitivity test to SDS. V. cholerae cells harboring 
the empty plasmid as a control, or the plasmid 
encoding the constructs of interest were grown in 
LB medium at 30°C until stationary phase, then 
back diluted to initial OD595nm=0.2 in LB 
supplemented or not with SDS 0.125%, and grown 
for 7 hrs at 30°C with agitation. The percentage of 
surviving cells was estimated from the turbidity 
ratio of the SDS-treated cells and the control 
samples. Experiments were performed in 
triplicates. Sensitivity test to deoxycholate. 
Normalized serial dilutions of strains to be tested 
were spotted onto 1% deoxycholate (DOC)-
supplemented LB plates. After O/N incubation at 
37°C, survival was reported as the highest dilution 
of strain able to form colonies. Growth in low 
osmolarity conditions. The different strains were 
grown in LB medium at 30°C until stationary 
phase, then back diluted 100-fold in LB medium 
(osmolarity 407 mOsM) and in Tryptone broth 
(1% (w/v) Tryptone, 66 mM NaCl; pH 8.5; 123 
mOsM, (64)), and incubated for 16 hrs at 30°C.  
The percentage of growth was estimated from the 
turbidity ratio of the tested strains and the control 
sample. Experiments were performed in 
triplicates.  
CTX-cm phage particle preparation— The dif1– 
strain BS2 (71) harboring the chloramphenicol-
marked CTXEl Tor phage replicative form (pCTX-
cm) was used as a donor strain to produce CTX 
phage particles. The donor strain was streaked 
onto LB cm1 plates, and incubated at 37°C 
overnight. A single colony was used to inoculate a 
2 mL LB + Sm100 culture and incubated at 37°C 
for 16 hours. Cell were pelleted by centrifugation 
and the supernatant containing phages was filter-
sterilized using 0,22 um syringe filter. Phage 
preparation was checked for sterility by plating on 
LB plate. 
Susceptibility to CTX phage infection assays— 
Cell susceptibility to phage infection was 
conducted as previously described (72). Briefly, 
for each recipient strain, 3 independent clones 
were cultivated separately in TCP-inducing 
conditions (LB 1% tryptone, 0.5% yeast extract, 
0.5% NaCl, pH 6.5, 30°C). After 20 hrs of growth, 
75 µl of cells were mixed with 75 µl of CTX-cm 
phage suspension. The mixture was incubated 
during 30 min at room temperature without 
shaking, then 500 µl of LB were added and the cell 
suspension was incubated at 37°C with vigorous 
shaking for 45 min to allow cell recovery. Then 
dilutions of the cell suspension were plated on LB 
agar plates supplemented with Sm (100) or with 
Sm (50) Cm (1) to enumerate total cells and 
transductant cells, respectively. The frequency of 
infection was determined by dividing the number 
of transductants by the number of total recipient 
cells. 
NMR spectroscopy— For NMR studies a TolA237-
356
Vc (TolAIII Vc) construct was included in a 
plasmid with the gene of OmpA signal sequence 
for protein secretion at the N-terminus and 6-
HisTag for the purification at the C-terminus. For 
the native and variant pIII-N1CTX, OmpA signal 
sequence and 6-HisTag construct were used, with 
an additional strepTag at the N-terminal of the 
gene sequence. 15N-isotopic labelling of native and 
mutant pIII-N1CTX were obtained from bacteria 
grown on M9 medium containing 1g/L 15NH4Cl as 
sole source of nitrogen. The proteins were 
overexpressed in E. coli BL21 strain. Protein 
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production was obtained after 2h IPTG induction 
at 37°C. Protein purification was obtained from 
periplasmic extract pulled on Ni-NTA agarose and 
eluted with imidazole step gradient.  
 NMR spectra were recorded on a Bruker 600MHz 
spectrometer equipped with a TCI cryoprobe, at 
300K. 1H-15N HSQC spectra were processed with 
TopSpin software. For NMR experiments pIII-
N1CTX wild type and (E37Q-D39N) double 
mutant, the concentration was 0.16mM in 50mM 
NaPO4, 50 mM NaCl buffer at pH 6.9. In the case 
of the complexes, the final TolAIIIVc concentration 
was 0.32mM. 
In silico analysis — Search for V. cholerae O395 
TolA orthologous sequences was performed with 
BlastP, and restricted to Vibrionaceae species 
using TaxReport (http://annotathon.org/). 
Multisequence alignments were performed using 
Clustal Omega (73) and color coded with 
JalView2 tool (74). The 2P2I database (51, 52) 
was used to list all the non-bonded contacts at the 
complex interface (PDB #4G7X) with a cuf-off 
distance of 4 Å. 
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FIGURE LEGENDS 
 
FIGURE 1. The pIII-N1CTX and pIII-N1M13 domains specifically interact with their cognate TolA 
partner. (A) Crystal structure of V. cholerae TolAIII (yellow) in complex with CTXΦ pIII-N1 (grey, 
PDB #4G7X), and superimposed to E. coli TolAIII (red) in complex with M13Φ pIII-N1 (green, PDB 
#1TOL). (B) Bacterial two hybrid assay: E. coli BTH101 or Oxi-BTH reporter cells producing the 
indicated domains fused to the T18 or T25 domain of the Bordetella pertussis adenylate cyclase were 
spotted on MacConkey plates. The red color of the spot reflects the interaction between tested domains. 
ColAN (N-terminal colicin A domain), pIII-N1CTX (N-ter domain of CTXΦ pIII protein), pIII-N1M13 (N-ter 
domain of M13-phage pIII protein), TolAIII (C-ter domain of E. coli or V. cholerae TolA protein).  
 
FIGURE 2. pIII-N1CTX disulfide bonds II and III are required for TolAIIIVc interaction. (A) 
Schematic representation of disulfide bond localization (according to (15)) on the secondary structure of 
TolAIIIVc and pIII-N1CTX, and (B) representation of disulfide bonds on the crystal structure of the 
complex. Disulfide bonds in pIII-N1 are numbered I to IV and colored in red. Italic numbers refer to 
cysteine residue positions. (C) Oxidative bacterial two-hybrid assay : Oxi-BTH reporter cells producing 
the T25 domain fused to pIII-N1CTX, pIII-N1N2CTX or pIII-N2CTX domains, and the T18 domain fused to V. 
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cholerae TolAIII were spotted on MacConkey plates. Variants bearing substitutions aimed to abolish each 
of the four disulfide bonds in the pIII-N1CTX domain (C32S, C47S, C75S, C96S) or in TolAIIIVc (C292S) 
are presented. TolAIIIEc and pIII-N1M13 are used as a controls. n.t. not tested.  
 
FIGURE 3. pIII-N1CTX-TolAIIIVc binding relies on two salt bridges. (A) Left: schematic representation 
of the V. cholerae TolAIII and CTX phage pIII-N1 secondary structure. Residues (black arrows) engaged 
into intermolecular salt-bridges (dotted lines) and disulfide bonds (black lines) are pointed out. Right : x-
ray structure of the complex showing the three key salt bridges. (B) Western immunoblot of 0.2 OD units 
of whole-cell lysates of E. coli DH5⍺ strain carrying T18-TolAIIIVc construct, or variants of interest, and 
probed with anti-T18 antibody. The molecular weight markers (in kDa) are indicated on the left. (C) 
TolAIIIVc and pIII-N1CTX point mutants were tested for their binding ability, in comparison to the wild 
type constructs, in an Oxi-BTH assay on MacConkey plates. TolAIIIEc and pIII-N1M13 are used as a 
controls. n.t. not tested.  
 
FIGURE 4. (A) 1H-15N HSQC of 15N-labelled pIII-N1CTX domain, (B) 1H-15N HSQC of 15N-labelled pIII-
N1CTX domain in the absence (in black) and in the presence of TolAIIIVc domain (in red), (C) 1H-15N 
HSQC of 15N-labelled pIII-N1CTX (E92K) domain, (D) 1H-15N HSQC of 15N-labelled pIIIN1CTX(E92K) 
domain in the absence (in black) and in the presence of TolAIIIVc domain (in red). (E) 1H-15N HSQC of 
15N-labelled pIIIN1CTX(E37Q-D39N) domain, (F) 1H-15N HSQC of 15N-labelled pIIIN1CTX(E37Q-D39N)  
domain in the absence (in black) and in the presence of TolAIIIVc domain (in red). 
 
FIGURE 5. Periplasmic production of CTXΦ pIII-N1 domain or variants in V. cholerae and 
phenotypic characterization. Precultures of V. cholerae O395 cells carrying various pIN constructs were 
grown in LB supplemented with MgCl2 to promote OM integrity and cell growth. (A) CTX transduction 
assay were conducted in triplicate, and CFU were counted on LB or LB supplemented with Cm. 
Frequency of infection is calculated by dividing the number of transductants (CmR colonies) by the 
number of O395 recipients. The mean and the standard deviation of the triplicate is presented. For each 
construct, infection efficiency is expressed as the percentage of infection compared to the receiver strain 
carrying the empty vector. (B) Membrane integrity assay. 4 µl of 10-fold dilution of normalized cultures 
(initial OD595=1) were spotted on LB+amp plates alone or supplemented with 1% DOC. (C) Percentage of 
survival to SDS 0.125% of the different strains compared to V. cholerae WT strain carrying a pIN empty 
vector. For each strain, percentage of growth is calculated as OD600 nm of each stain grown in LB+SDS x 
100 / OD600 nm of the WT strain carrying an empty vector and grown in LB. The experiments were 
conducted in triplicate, and the standard deviation is presented. 
 
FIGURE 6. Phenotypic characterization of V. cholerae O395 WT and TolA- strains complemented 
with TolA variants of interest. (A) Expression of the different pBAD-TolAVc constructs in V. cholerae 
was assessed by western immunobloting. A total of 0.3 OD units of whole cell lysate were loaded on a 
13.5% acrylamide gel SDS-PAGE and immunodetected using polyclonal antibody raised against E. coli 
TolA. (B) CTX transduction assays were conducted in triplicate, and CFU were counted on LB or LB 
supplemented with Cm. Frequency of infection is calculated by dividing the number of transductants 
(CmR colonies) by the number of O395 recipients. The mean and the standard deviation of the triplicate 
is presented. For each construct, infection efficiency is expressed as the percentage of infection compared 
to the receiver strain carrying the empty vector. (C) Membrane integrity assay. 4 µl of 5-fold dilution of 
normalized cultures (initial OD600=1) were spotted on LB+Km plates alone or supplemented with 1% 
DOC. (D) Percentage of survival to SDS 0.125% of the different strains compared to V. cholerae WT 
strain carrying an pBAD empty vector. For each strain, percentage of growth is calculated as OD600 nm of 
each stain grown in LB+SDS x 100 / OD595 nm of the WT strain carrying an empty vector and grown in 
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LB. (E) Quantification of V. cholerae O395 WT and TolA- mutant growth in LB (407 mOsm) and in 
Tryptone broth (TB) supplemented with 66 mM NaCl (123 mOsm). The experiment was conducted in 
triplicate and the error bars report standard deviations. 
 
FIGURE 7. Conservation of TolA K324 and R325 residues in other Vibrio species. (A) Sequence 
alignment between V. cholerae, V. tasmaniensis, V. anguillarum, V. alginolyticus, V. harveyi and V. 
fisheri TolAIII β2-⍺2 domain. Residues are colored as follow: basic (black squares), acidic (bold), 
hydrophobic (light grey), polar uncharged (dark grey). Black arrows point the K324 R325 motif. (B) 
Western immunoblot of 0.2 OD units of whole-cell lysates of E. coli DH5⍺ strain carrying T18-TolAIII 
construct from selected Vibrionaceae and from E. coli, and probed with anti-Cya antibody. The molecular 
weight markers (in kDa) are indicated on the left. (C) T18-TolAIII constructs from selected species were 
tested for their binding ability to the T25-pIII-N1CTX in an Oxi-BTH assay on MacConkey plates. E. coli 
TolAIII and pIII-N1M13 are used as a controls. Sequence comparison between each TolAIII of interest and 
the V. cholerae TolAIII amino acid sequences using Blast2 is reported on the right of the panel as E 
value, identity (I) and positive (P) values.  
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